Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9018 |
High Similarity |
NPD3818 |
Discontinued |
0.8981 |
High Similarity |
NPD1934 |
Approved |
0.8924 |
High Similarity |
NPD2801 |
Approved |
0.8882 |
High Similarity |
NPD5494 |
Approved |
0.8795 |
High Similarity |
NPD7074 |
Phase 3 |
0.875 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8735 |
High Similarity |
NPD7054 |
Approved |
0.8696 |
High Similarity |
NPD3882 |
Suspended |
0.8688 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8683 |
High Similarity |
NPD7472 |
Approved |
0.8529 |
High Similarity |
NPD7808 |
Phase 3 |
0.8528 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8521 |
High Similarity |
NPD6797 |
Phase 2 |
0.8471 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8471 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8443 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8443 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8443 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8405 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8365 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8354 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8323 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8323 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8284 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8269 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8256 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8214 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8199 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.8187 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8187 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8187 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8171 |
Intermediate Similarity |
NPD37 |
Approved |
0.8155 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8155 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.8144 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8133 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8133 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8133 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8121 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8121 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8084 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8077 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8072 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8059 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.8049 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8038 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7976 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7963 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7963 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7963 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7953 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7941 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7935 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7929 |
Intermediate Similarity |
NPD919 |
Approved |
0.7919 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7911 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7901 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7892 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7886 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7865 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7834 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7831 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7816 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7771 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7747 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7738 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7735 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7711 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7707 |
Intermediate Similarity |
NPD943 |
Approved |
0.7701 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7688 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7658 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7658 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7651 |
Intermediate Similarity |
NPD920 |
Approved |
0.764 |
Intermediate Similarity |
NPD2344 |
Approved |
0.764 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7613 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7602 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7595 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7595 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7578 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7578 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7564 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7556 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7556 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7546 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7542 |
Intermediate Similarity |
NPD7240 |
Approved |
0.753 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7486 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7468 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.746 |
Intermediate Similarity |
NPD6780 |
Approved |
0.746 |
Intermediate Similarity |
NPD6779 |
Approved |
0.746 |
Intermediate Similarity |
NPD6782 |
Approved |
0.746 |
Intermediate Similarity |
NPD6776 |
Approved |
0.746 |
Intermediate Similarity |
NPD6781 |
Approved |
0.746 |
Intermediate Similarity |
NPD6778 |
Approved |
0.746 |
Intermediate Similarity |
NPD6777 |
Approved |
0.746 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7456 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7455 |
Intermediate Similarity |
NPD2309 |
Approved |
0.744 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7439 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7425 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7423 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.741 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7407 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7394 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7353 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7344 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7344 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7344 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7344 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7342 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7338 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7337 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7325 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7322 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7321 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7306 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7306 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7303 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7301 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7293 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7292 |
Intermediate Similarity |
NPD5006 |
Approved |
0.7292 |
Intermediate Similarity |
NPD5005 |
Approved |
0.7288 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7284 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7278 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7259 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7259 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.725 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.725 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7247 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7241 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7202 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7196 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7196 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7194 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7179 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7173 |
Intermediate Similarity |
NPD4420 |
Approved |
0.7172 |
Intermediate Similarity |
NPD7801 |
Approved |
0.717 |
Intermediate Similarity |
NPD9494 |
Approved |
0.716 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7121 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7121 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.712 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7117 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7115 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.711 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7108 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7105 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7091 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7074 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7069 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7068 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7068 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7044 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7037 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7029 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7025 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7024 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7019 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7018 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7012 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD5019 |
Clinical (unspecified phase) |
0.699 |
Remote Similarity |
NPD7680 |
Approved |
0.6987 |
Remote Similarity |
NPD17 |
Approved |
0.6982 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6982 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6971
|
Remote Similarity |
NPD6386 |
Approved |